NKF Capabilities

Global leader in API manufacturing

  • Heparin and LMW Heparin – 20% of global supply

  • Meets health bureau inspections: Germany, CFDA – China, PMDA – Japan and US FDA

  • EDQM, EU approved

Two state-of-the-art FDF facilities

  • Fully integrated isolator systems for advanced safety, purity, efficacy
  • CFDA China and US FDA approved
  • Locations: Nanjing and Chengdu

Nanjing FDF & API Plants

FDF Plant

  • Established in 2011
  • Fully Integrated Isolator System
  • Line 1 Pre-filled syringe; capacity 600 Syringes/min.
  • Line 2 Vials; capacity 400 vials/min.

API Plant

  • Heparin  and LMWH
  • Enoxaparin sodium API

Chengdu FDF Plant

Vials (liquid & lyophilized) 

  • Established in December 2006
  • Both Solution & Lyo Products
  • Capacity 120 Vials/min.
  • Fully Integrated Isolator System